To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FBXO45TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
193 supporting clones for gene FBXO45 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB636416 testis .a 1 to 618 1 to 618   tiling clone,   618/659
(93 %)
36 diff
(94.6 %id)
AL041104 testis .a 14 to 425 1 to 413       413/414
(99 %)
2 diff
(99.6 %id)
BE302627 melanotic melanoma, skin .a 33 to 371 1 to 340       340/340
(100 %)
2 diff
(99.5 %id)
BE302945 melanotic melanoma, skin .a 34 to 372 1 to 339       339/339
(100 %)
0 diff
(100 %id)
DB636435 hippocampus .a 209 to 838 1 to 631       631/728
(86 %)
18 diff
(97.6 %id)
DB636510 hippocampus .a 209 to 889 1 to 680   tiling clone,   680/680
(100 %)
25 diff
(96.4 %id)
NM_001105573.1   .a 212 to 5942 1 to 5731   RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 5731/5731
(100 %)
0 diff
(100 %id)
BU521386 leiomyosarcoma, uterus .a 296 to 1083 1 to 793       793/903
(87 %)
12 diff
(98.7 %id)
BU184347 leiomyosarcoma, uterus .a 301 to 828 1 to 527       527/1012
(52 %)
51 diff
(95.0 %id)
DR001950 fetal brain .a 361 to 987 1 to 627       627/635
(98 %)
10 diff
(98.5 %id)
BE887634 leiomyosarcoma, uterus .a 418 to 1118 1 to 711       711/996
(71 %)
20 diff
(98.0 %id)
DA122443 cerebellum .a 440 to 997 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DN998192 breast cancer, Mammary gland (cancer tissue) .a 469 to 1156 1 to 688       688/688
(100 %)
6 diff
(99.2 %id)
BE778263 eye, retinoblastoma .a 563 to 1346 1 to 778       778/809
(96 %)
22 diff
(97.3 %id)
CK902856 Pancreas, Purified pancreatic islet .a 629 to 1053 1 to 421     Submitted on the opposite strand 421/421
(100 %)
4 diff
(99.1 %id)
DA405718 thalamus .a 708 to 1197 2 to 491   tiling clone, capped   490/490
(100 %)
0 diff
(100 %id)
BF685097 leiomyosarcoma cell line, uterus .a 728 to 1510 1 to 780       780/890
(87 %)
25 diff
(97.2 %id)
H04181 placenta .a 787 to 1152 1 to 375       375/446
(84 %)
18 diff
(96.0 %id)
BE542925 cervix .a 790 to 1425 1 to 653       653/965
(67 %)
37 diff
(96.2 %id)
CB116148 Liver .a 830 to 1382 1 to 553       553/553
(100 %)
17 diff
(97.0 %id)
CA774609 Pancreas, Purified pancreatic islet .a 952 to 1759 808 to 1       808/808
(100 %)
1 diff
(99.9 %id)
AA383580 testis .a 962 to 1166 1 to 205       205/205
(100 %)
0 diff
(100 %id)
DA446725 tongue, tumor tissue .a 990 to 1491 2 to 504   capped   503/503
(100 %)
2 diff
(99.7 %id)
BU928035 mixed (pool of 40 RNAs) .a 1039 to 1763 1 to 726       726/730
(99 %)
7 diff
(99.1 %id)
BQ024761 placenta .a 1128 to 1757 649 to 20   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 630/630
(100 %)
3 diff
(99.6 %id)
CA445163 lung, Metastatic Chondrosarcoma .a 1128 to 1759 651 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 633/633
(100 %)
1 diff
(99.9 %id)
BQ440009 eye, retinoblastoma .a 1208 to 2067 1 to 869       869/869
(100 %)
13 diff
(98.6 %id)
BF590021 Kidney .a 1220 to 1759 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BQ021825 placenta .a 1270 to 1759 507 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 490/490
(100 %)
0 diff
(100 %id)
BU754391 placenta .a 1270 to 1759 508 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 490/490
(100 %)
0 diff
(100 %id)
BE207480 melanotic melanoma, skin .a 1298 to 1761 464 to 1       464/464
(100 %)
0 diff
(100 %id)
CK902857 Pancreas, Purified pancreatic islet .a 1303 to 1765 463 to 1     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AI817860 colon, colon tumor, RER+ .a 1326 to 1757 436 to 3       434/436
(99 %)
0 diff
(100 %id)
FN130107 breast carcinoma .a 1331 to 1406 1 to 73       73/77
(94 %)
4 diff
(94.9 %id)
AI656790 pooled germ cell tumors .a 1336 to 1759 424 to 1       424/424
(100 %)
0 diff
(100 %id)
H15428 whole brain .a 1341 to 1769 431 to 1       431/431
(100 %)
6 diff
(98.7 %id)
CA842811 Pancreas, Purified pancreatic islet .a 1344 to 1758 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI809503 pooled .a 1359 to 1769 411 to 1       411/411
(100 %)
1 diff
(99.8 %id)
W44928.
matches multiple genes
senescent fibroblast .a 1360 to 1759 404 to 1     Submitted on the opposite strand, also hits gene RYBP 404/404
(100 %)
4 diff
(99.1 %id)
AA977754 2 pooled tumors (clear cell type), Kidney .a 1363 to 1762 400 to 1       400/400
(100 %)
0 diff
(100 %id)
H04182 placenta .a 1370 to 1759 399 to 1       399/401
(99 %)
12 diff
(97.1 %id)
AW195255 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 1375 to 1761 394 to 8       387/394
(98 %)
0 diff
(100 %id)
AW268469 pooled .a 1418 to 1762 345 to 1       345/345
(100 %)
0 diff
(100 %id)
DA780912 brain .a 1426 to 1969 2 to 547   capped   546/546
(100 %)
4 diff
(99.3 %id)
AA757976   .a 1428 to 1765 338 to 1       338/338
(100 %)
1 diff
(99.8 %id)
AA280995 germinal center B cell .a 1476 to 1722 1 to 247       247/247
(100 %)
2 diff
(99.2 %id)
DA531201 brain .a 1491 to 2103 2 to 614   capped   613/613
(100 %)
1 diff
(99.9 %id)
AA933911 pooled .a 1531 to 1767 237 to 1       237/237
(100 %)
0 diff
(100 %id)
T03548   .a 1539 to 1759 222 to 1       222/222
(100 %)
3 diff
(98.7 %id)
AA085971   .a 1556 to 1963 10 to 429       420/430
(97 %)
20 diff
(95.4 %id)
DB072681 testis .a 1567 to 2094 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
AW978832   .a 1598 to 2216 619 to 1   tiling clone, Submitted on the opposite strand 619/619
(100 %)
9 diff
(98.6 %id)
BQ027632 mixed .a 1640 to 1759 138 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 120/120
(100 %)
0 diff
(100 %id)
TI_149306196   .a 1641 to 2427 111 to 894     Submitted on the opposite strand 784/1020
(76 %)
6 diff
(99.5 %id)
BU686261 lung, Primary Lung Epithelial Cells .a 1641 to 2137 6 to 508     Submitted on the opposite strand 503/516
(97 %)
12 diff
(97.7 %id)
BM147064 leukopheresis .a 1645 to 2112 1 to 468   AAA   468/468
(100 %)
1 diff
(99.8 %id)
BM149160 leukopheresis .a 1645 to 2065 1 to 421       421/421
(100 %)
54 diff
(87.2 %id)
BM147575 leukopheresis .a 1645 to 1977 1 to 335       335/355
(94 %)
7 diff
(98.1 %id)
BM147576 leukopheresis .a 1645 to 1995 1 to 352   AAA   352/352
(100 %)
9 diff
(97.5 %id)
BM146531 leukopheresis .a 1645 to 2021 1 to 378       378/378
(100 %)
22 diff
(94.2 %id)
DA796719 brain .a 1654 to 2200 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB244157 uterus, tumor tissue .a 1658 to 2211 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
FN111204 breast carcinoma .a 1663 to 1757 1 to 95       95/97
(97 %)
2 diff
(98.0 %id)
AL540179 brain, fetal brain .a 1765 to 2779 1 to 1012       1012/1019
(99 %)
6 diff
(99.5 %id)
AA280817 germinal center B cell .a 1768 to 2217 450 to 1       450/450
(100 %)
0 diff
(100 %id)
DA294724 hippocampus .a 1783 to 2345 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
AA707904 pineal gland .a 1787 to 2216 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AI017178 pooled .a 1829 to 2280 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
CB128901 Liver .a 1911 to 2583 1 to 672       672/672
(100 %)
2 diff
(99.8 %id)
AA836455 germinal center B cell .a 2016 to 2224 211 to 3       209/211
(99 %)
0 diff
(100 %id)
AW187985 pooled .a 2049 to 2280 233 to 1       233/233
(100 %)
6 diff
(97.5 %id)
DB014142 esophageal, tumor tissue .a 2063 to 2629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA523332 brain .a 2066 to 2633 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BM786891 stomach .a 2073 to 2767 1 to 697       697/697
(100 %)
1 diff
(99.9 %id)
CV574015 cornea, eye .a 2078 to 2718 1 to 641       641/641
(100 %)
0 diff
(100 %id)
DB108903 thymus .a 2082 to 2664 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA694338   .a 2168 to 2707 2 to 544   capped   543/543
(100 %)
3 diff
(99.5 %id)
BQ422364 embryonal carcinoma, cell line, testis .a 2184 to 2997 1 to 817   tiling clone,   817/873
(93 %)
19 diff
(97.9 %id)
BE080698 breast .a 2197 to 2703 8 to 513       506/514
(98 %)
6 diff
(98.9 %id)
AA301250 testis .a 2217 to 2400 1 to 184       184/184
(100 %)
0 diff
(100 %id)
DA745004   .a 2224 to 2782 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BF103672 embryonal carcinoma, testis .a 2233 to 2874 1 to 640       640/723
(88 %)
21 diff
(97.1 %id)
DA727585   .a 2272 to 2957 2 to 694   capped   693/773
(89 %)
14 diff
(98.2 %id)
DB045704 testis .a 2289 to 2846 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
CX866395 embryonic stem .a 2437 to 3171 1 to 735     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 735/735
(100 %)
3 diff
(99.6 %id)
W05676 lung .a 2466 to 2704 9 to 247       239/270
(88 %)
1 diff
(99.7 %id)
AA287417 germinal center B cell .a 2487 to 3003 1 to 517       517/517
(100 %)
0 diff
(100 %id)
AA303277 aorta .a 2513 to 2840 1 to 329       329/333
(98 %)
3 diff
(99.1 %id)
Z46036 brain, total brain .a 2601 to 2936 1 to 336       336/336
(100 %)
0 diff
(100 %id)
BG679854 skin, squamous cell carcinoma .a 2744 to 3530 1 to 785       785/786
(99 %)
10 diff
(98.8 %id)
BF209673 bone marrow, from chronic myelogenous leukemia .a 2759 to 3359 1 to 604       604/604
(100 %)
20 diff
(96.7 %id)
BF209918 bone marrow, from chronic myelogenous leukemia .a 2760 to 3437 1 to 661       661/844
(78 %)
40 diff
(95.3 %id)
Z44376 brain, total brain .a 2777 to 3104 1 to 328       328/328
(100 %)
2 diff
(99.4 %id)
BU175845 large cell carcinoma, lung .a 2797 to 3272 81 to 563       483/1324
(36 %)
19 diff
(98.6 %id)
BM846975 myeloma .a 2824 to 3151 1 to 328       328/328
(100 %)
3 diff
(99.1 %id)
BG497421 lung, mucoepidermoid carcinoma .a 2839 to 3390 1 to 558       558/690
(80 %)
26 diff
(96.3 %id)
CF140200 CNCAP(3)T-225 cell line, Prostate .a 2856 to 3340 7 to 491   tiling clone,   485/491
(98 %)
0 diff
(100 %id)
TI_154170576   .a 2856 to 3504 79 to 729       651/877
(74 %)
19 diff
(97.9 %id)
BF817671 colon_ins .a 2889 to 3384 501 to 7     Submitted on the opposite strand 495/501
(98 %)
0 diff
(100 %id)
AW801616 uterus .a 2923 to 3286 14 to 377       364/377
(96 %)
6 diff
(98.5 %id)
AA336384 endometrium .a 2941 to 3359 1 to 412       412/416
(99 %)
16 diff
(96.2 %id)
AW960644   .a 2942 to 3545 1 to 601       601/607
(99 %)
15 diff
(97.6 %id)
AL568268 brain, fetal brain .a 3057 to 4153 1087 to 1       1087/1087
(100 %)
18 diff
(98.4 %id)
AV722927 hypothalamus .a 3113 to 3541 1 to 419       419/419
(100 %)
9 diff
(97.9 %id)
AA126570 uterus .a 3134 to 3307 1 to 174   fully sequenced,   174/174
(100 %)
1 diff
(99.5 %id)
BG538579 lung .a 3154 to 3938 1 to 779       779/779
(100 %)
16 diff
(98.0 %id)
AI539194 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3160 to 3465 19 to 327     Submitted on the opposite strand 309/327
(94 %)
6 diff
(98.2 %id)
BE933064 head_neck .a 3165 to 3426 1 to 259       259/259
(100 %)
14 diff
(94.6 %id)
AW298523   .a 3180 to 3558 1 to 379     Submitted on the opposite strand 379/389
(97 %)
9 diff
(97.7 %id)
AA372815 colon .a 3219 to 3495 1 to 277       277/277
(100 %)
2 diff
(99.3 %id)
CN361048 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3222 to 3556 1 to 335       335/335
(100 %)
0 diff
(100 %id)
BE936578 nervous_tumor .a 3224 to 3466 280 to 37       244/280
(87 %)
0 diff
(100 %id)
BM743341 Ascites, stomach .a 3227 to 3722 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
BM756135 Ascites, stomach .a 3227 to 3844 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
BM770760 Ascites, stomach .a 3227 to 3727 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BM748431 Ascites, stomach .a 3227 to 3685 1 to 459       459/459
(100 %)
3 diff
(99.4 %id)
BM748282 Ascites, stomach .a 3227 to 3777 1 to 551       551/551
(100 %)
3 diff
(99.5 %id)
BM748303 Ascites, stomach .a 3227 to 3419 1 to 197       197/197
(100 %)
5 diff
(97.5 %id)
BM749769 Ascites, stomach .a 3227 to 3741 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
BM758952 Ascites, stomach .a 3227 to 3831 1 to 604   tiling clone,   604/604
(100 %)
1 diff
(99.9 %id)
BM758584 Ascites, stomach .a 3227 to 3778 1 to 552       552/552
(100 %)
0 diff
(100 %id)
AW014898   .a 3266 to 3797 531 to 1       531/531
(100 %)
3 diff
(99.5 %id)
AA126446 uterus .a 3277 to 3779 504 to 1   fully sequenced,   504/504
(100 %)
4 diff
(99.3 %id)
AI435795 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3310 to 3786 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AI675702 Prostate .a 3310 to 3781 472 to 1       472/472
(100 %)
2 diff
(99.6 %id)
BM477306 lymph, lymphoma, cell line .a 3326 to 4025 1 to 697       697/1055
(66 %)
29 diff
(97.3 %id)
N74976 lung .a 3337 to 3779 451 to 1       451/452
(99 %)
5 diff
(98.9 %id)
AW058438 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3337 to 3786 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI095712 uterus .a 3339 to 3789 451 to 1       451/451
(100 %)
2 diff
(99.6 %id)
BU620966 cell lines, Chondrosarcoma .a 3348 to 4169 836 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 818/818
(100 %)
4 diff
(99.6 %id)
AA287270 germinal center B cell .a 3357 to 3779 423 to 1       423/423
(100 %)
3 diff
(99.3 %id)
BU507919 leiomyosarcoma, uterus .a 3380 to 4170 1 to 790       790/799
(98 %)
2 diff
(99.8 %id)
BF981830 duodenal adenocarcinoma, cell line, small intestine .a 3384 to 4059 1 to 674       674/924
(72 %)
15 diff
(98.4 %id)
BE180083 head_neck .a 3393 to 4027 634 to 1     Submitted on the opposite strand 634/634
(100 %)
7 diff
(98.9 %id)
AI400760 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3396 to 3779 382 to 1       382/382
(100 %)
2 diff
(99.5 %id)
BQ008531 Chondrosarcoma, Left Pubic Bone .a 3414 to 4170 773 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 755/756
(99 %)
2 diff
(99.8 %id)
Z40309 brain, total brain .a 3422 to 3786 365 to 1       365/365
(100 %)
0 diff
(100 %id)
CX866320 embryonic stem .a 3512 to 4170 685 to 27   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 659/659
(100 %)
1 diff
(99.9 %id)
AA085826   .a 3738 to 4149 417 to 1       417/417
(100 %)
5 diff
(98.9 %id)
Z41645 brain, total brain .a 3930 to 4170 241 to 1       241/241
(100 %)
0 diff
(100 %id)
AK025697   .b 1 to 3687 1 to 3684   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3684/3684
(100 %)
4 diff
(99.9 %id)
DB086325 testis .b 6 to 557 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA506531 brain .b 2956 to 3533 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
FN048017 breast carcinoma .b 2960 to 3053 94 to 1     Submitted on the opposite strand 94/94
(100 %)
0 diff
(100 %id)
FN162509 breast carcinoma .b 2970 to 3059 90 to 1     Submitted on the opposite strand 90/95
(94 %)
2 diff
(97.9 %id)
DB530038 hippocampus .b 2971 to 3687 1 to 716     Submitted on the opposite strand 716/716
(100 %)
6 diff
(99.2 %id)
T93694 lung .b 2984 to 3139 1 to 153       153/153
(100 %)
4 diff
(97.4 %id)
BU619599 Cell Line, Chondrosarcoma .b 2988 to 3687 714 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 700/700
(100 %)
0 diff
(100 %id)
BQ775391 Bone, Human Chondrosarcoma Cell Line .b 2992 to 3687 712 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 694/694
(100 %)
3 diff
(99.6 %id)
AW801743 uterus .b 3000 to 3401 402 to 1       402/402
(100 %)
5 diff
(98.8 %id)
AA425408   .b 3010 to 3533 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
DB540587 hippocampus .b 3013 to 3687 1 to 674     Submitted on the opposite strand 674/674
(100 %)
3 diff
(99.6 %id)
BE540255 cervix .b 3018 to 3609 1 to 590       590/800
(73 %)
7 diff
(99.2 %id)
BQ188291 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3020 to 3344 1 to 325   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 325/325
(100 %)
0 diff
(100 %id)
FN062970 breast carcinoma .b 3023 to 3121 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BM995638 Chondrosarcoma, Left Pubic Bone .b 3024 to 3687 681 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
BQ007088 Chondrosarcoma, Left Pelvis .b 3025 to 3687 681 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 663/663
(100 %)
0 diff
(100 %id)
DB527893 testis .b 3035 to 3687 1 to 655     Submitted on the opposite strand 655/655
(100 %)
11 diff
(98.4 %id)
CD677723 eye, Trabecular meshwork .b 3074 to 3687 1 to 614   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
AW801446 uterus .b 3088 to 3380 295 to 2       294/295
(99 %)
0 diff
(100 %id)
BU631983 cell lines, Chondrosarcoma .b 3117 to 3687 589 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 571/571
(100 %)
3 diff
(99.5 %id)
AI655782 pooled germ cell tumors .b 3132 to 3687 556 to 1       556/556
(100 %)
0 diff
(100 %id)
AI458074 pooled .b 3141 to 3689 552 to 3       550/552
(99 %)
0 diff
(100 %id)
AW003463 pooled germ cell tumors .b 3153 to 3687 536 to 1       536/536
(100 %)
4 diff
(99.3 %id)
AA628904   .b 3211 to 3689 479 to 2       478/479
(99 %)
0 diff
(100 %id)
AI633665 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3221 to 3685 467 to 3       465/467
(99 %)
0 diff
(100 %id)
AI653095 pooled germ cell tumors .b 3222 to 3687 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BF057293 pooled germ cell tumors .b 3222 to 3687 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI335755 pooled germ cell tumors .b 3227 to 3687 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AA668788 germinal center B cell .b 3256 to 3687 463 to 33   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 431/431
(100 %)
1 diff
(99.8 %id)
BE045562 carcinoid, lung .b 3267 to 3689 424 to 2   tiling clone,   423/424
(99 %)
0 diff
(100 %id)
AI151180 placenta .b 3273 to 3687 414 to 1       414/414
(100 %)
4 diff
(99.1 %id)
AI092571 parathyroid gland, parathyroid tumor .b 3279 to 3689 415 to 5       411/415
(99 %)
0 diff
(100 %id)
AA482978 alveolar rhabdomyosarcoma .b 3298 to 3687 403 to 11       393/419
(93 %)
0 diff
(100 %id)
AW589960 pooled germ cell tumors .b 3300 to 3687 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
AI637773 pooled germ cell tumors .b 3301 to 3687 387 to 1       387/387
(100 %)
0 diff
(100 %id)
BE466832 pooled germ cell tumors .b 3301 to 3687 387 to 1       387/387
(100 %)
3 diff
(99.3 %id)
AI367089   .b 3305 to 3689 391 to 7       385/391
(98 %)
0 diff
(100 %id)
AI521970 Kidney .b 3305 to 3687 410 to 28   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 383/383
(100 %)
0 diff
(100 %id)
R58849   .b 3314 to 3687 374 to 1       374/374
(100 %)
0 diff
(100 %id)
BQ185727 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3314 to 3683 387 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 371/371
(100 %)
0 diff
(100 %id)
T96159 lung .b 3323 to 3684 373 to 1       373/377
(98 %)
12 diff
(96.9 %id)
AW103644 brain, tumor, 5 pooled (see description) .b 3342 to 3689 353 to 6       348/353
(98 %)
0 diff
(100 %id)
AW472856 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3347 to 3687 341 to 1       341/341
(100 %)
1 diff
(99.8 %id)
AA773780   .b 3362 to 3672 312 to 1       312/312
(100 %)
1 diff
(99.7 %id)
BX400148   .b 3364 to 3658 295 to 1       295/299
(98 %)
3 diff
(99.0 %id)
AA992884   .b 3399 to 3689 293 to 3       291/293
(99 %)
0 diff
(100 %id)
T17290   .b 3433 to 3687 255 to 1       255/255
(100 %)
0 diff
(100 %id)
CD512464 Pooled-Skin .b 3441 to 3687 1 to 247   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 247/247
(100 %)
1 diff
(99.6 %id)
AA670305 whole brain .b 3462 to 3689 228 to 1       228/228
(100 %)
0 diff
(100 %id)
BU963835 mixed (pool of 40 RNAs) .b 3486 to 3686 1 to 201   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 201/201
(100 %)
1 diff
(99.6 %id)
BF477808 Prostate .b 3492 to 3687 196 to 1       196/196
(100 %)
0 diff
(100 %id)
BI060236 uterus_tumor .b 3525 to 3689 183 to 19       165/183
(90 %)
0 diff
(100 %id)
AW449481   .b 3539 to 3687 166 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 149/149
(100 %)
0 diff
(100 %id)
BX499201 Liver .b 3542 to 3992 1 to 451   tiling clone,   451/451
(100 %)
2 diff
(99.6 %id)
AW137337   .b 3560 to 3687 145 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 128/128
(100 %)
6 diff
(95.4 %id)
BU570963 brain, glioblastoma .b 4246 to 4847 1 to 605   tiling clone,   605/838
(72 %)
15 diff
(98.3 %id)
N79098 multiple sclerosis lesions .b 4652 to 5075 1 to 428   tiling clone, fully sequenced,   428/428
(100 %)
14 diff
(96.8 %id)
AA973128 pooled .b 4992 to 5461 469 to 1   tiling clone,   469/469
(100 %)
1 diff
(99.8 %id)
AI685281 pooled .b 5026 to 5461 437 to 2   tiling clone,   436/437
(99 %)
0 diff
(100 %id)
N62340 multiple sclerosis lesions .b 5045 to 5459 418 to 1   fully sequenced,   418/418
(100 %)
3 diff
(99.3 %id)
BE047625 brain, tumor, 5 pooled (see description) .b 5081 to 5459 22 to 400   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 379/400
(94 %)
6 diff
(98.5 %id)
H48863 liver and spleen .c-u 1 to 454 1 to 465 R16A H17T H18T T19P Q20S ... tiling clone,   465/469
(99 %)
20 diff
(95.8 %id)
H48586 liver and spleen .c-u 754 to 1071 319 to 1   tiling clone,   319/319
(100 %)
1 diff
(99.7 %id)
AV701672 adrenal gland Gene FBXO45, variant not shown         Suspected internal deletion, this clone was ignored    
AV714493   Gene FBXO45, variant not shown         Suspected internal deletion, this clone was ignored    
DA888846   Gene FBXO45, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI